It’s the Bethesda Declaration’s birthday — to mark the occasion, 73 NIHers have a report outlining ongoing concerns, which have become “more insidious and systematized, but no less harmful” as @jenna-m-norton.bsky.social put it
www.statnews.com/2026/06/09/n...
#Breaking: NIAID appoints new acting director after weeks-long questions over leadership www.statnews.com/2026/06/09/n...
We talked with Jenna and @ngfriedman.bsky.social about the report, hosted by @27unihted.bsky.social, and what the past year has meant for them
The NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.
In a report published on the first anniversary of the Bethesda Declaration, 71 staffers write that they feel NIH leadership “largely ignored" their concerns
www.statnews.com
anil oza
STAT
anil oza
After weeks of NIAID, the NIH's second largest institute, being in a leadership vacuum following Jeffrey Taubenberger stepping down, it has a new director: John H. Powers III
www.statnews.com/2026/06/09/n...
NEW: NIAID appoints new acting director after weeks-long questions over leadership. Via @aniloza.bsky.social
www.statnews.com/2026/06/09/n...
The NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.
The NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.
Fallout continues from the ADA's decision to forcibly expel five diabetes experts from its annual meeting in New Orleans for handing out copies of an editorial criticizing federal cuts to biomedical research. Liz Cooney has the latest:
www.statnews.com/2026/06/09/a...
The condemnations keep coming after five diabetes experts were escorted out of an ADA meeting for handing out copies of an editorial criticizing federal research cuts.
I spoke to @aniloza.bsky.social at STAT about how the latest executive order further presidentializes NIH. Schedule P/C undermines the fundamental philosophy of expert-led civil servant judgment that has made US science the envy of the world for 80+ years.
www.statnews.com/2026/06/05/s...
Yesterday I spoke to @aniloza.bsky.social about the paper @nataliebaviles.bsky.social and I wrote on NIH governance history — and what kind of governance works for science (presidential control does not work!)
Jason Ukman
#HHS refused for weeks to confirm what was widely known: Jeffery Taubenberger had been removed as acting director of #NIAID. Today HHS confirmed that John H. Powers is now acting director.
Why this happened & why HHS refused to admit it remains undisclosed. www.statnews.com/2026/06/09/n...
Thousands of HHS staff who shape policy have had their employment status changed to a designation that makes it easier for them to be fired.
The NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.
new eo dropped last night: Trump outlines who his administration intends to move into schedule F, making them easier to fire
At NIH, it includes the deputy directors of the agency and some branch chiefs/division directors
www.statnews.com/2026/06/03/t...
Among the affected positions, which the White House estimates to be 8,000, are high-level officials who oversee research grants from the NIH.
John Powers III will replace Jeffrey Taubenberger as NIAID's acting director. Powers, an infectious disease specialist who focuses on antimicrobials, worked as a contractor for NIAID and was employed by Leidos Biomedical, which runs NCI at Frederick. Taubenberger will return to his lab.
